Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Journal of Thrombosis and Haemostasis - Tập 18 Số 5 - Trang 1094-1099 - 2020
Ning Tang1, Huan Bai1, Xing Chen1, Jiale Gong1, Dengju Li2, Ziyong Sun1
1Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 10.1111/jth.14768

Singer, 2016, The third international consensus definitions for sepsis and septic shock (Sepsis‐3), JAMA, 315, 801, 10.1001/jama.2016.0287

2020, Comprehensive treatment and management of coronavirus disease 2019: expert consensus statement from Shanghai (in Chinese), Chin J Infect Dis, 38

Iba, 2019, Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation, J Thromb Haemost, 17, 1989, 10.1111/jth.14578

Iba, 2017, New criteria for sepsis‐induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey, BMJ Open, 7, 10.1136/bmjopen-2017-017046

World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Published January 28, 2020. https://www.who.int/publications‐detail/clinical‐management‐of‐severe‐acute‐respiratory‐infection‐whennovel‐coronavirus‐(ncov)‐infection‐is‐suspected. Accessed January 31, 2020

National Health Commission of China. The diagnosis and treatment plan for the novel coronavirus disease (the seventh edition). 2020.

Vincent, 1996, The SOFA (Sepsis‐related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis‐Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med, 22, 707, 10.1007/BF01709751

Venclauskas, 2018, European guidelines on perioperative venous thromboembolism prophylaxis: day surgery and fast‐track surgery, Eur J Anaesthesiol, 35, 134, 10.1097/EJA.0000000000000706

Levi, 2017, Coagulation and sepsis, Thromb Res, 149, 38, 10.1016/j.thromres.2016.11.007

Schmitt, 2019, Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study, Ann Intensive Care, 9, 19, 10.1186/s13613-019-0499-6

Gupta, 2019, The stimulation of thrombosis by hypoxia, Thromb Res, 181, 77, 10.1016/j.thromres.2019.07.013

Luo W, Yu H, Gou J, et al.Clinical pathology of critical patient with novel coronavirus pneumonia (COVID‐19). Preprints. 2020, 2020020407.

Poterucha, 2017, More than an anticoagulant: do heparins have direct anti‐inflammatory effects?, Thromb Haemost, 117, 437, 10.1160/TH16-08-0620

Stein, 2004, Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census, Am J Med, 116, 435, 10.1016/j.amjmed.2003.11.020

Zakai, 2011, Racial differences in venous thromboembolism, J Thromb Haemost, 9, 1877, 10.1111/j.1538-7836.2011.04443.x

Aikawa, 2011, Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial, Shock, 35, 349, 10.1097/SHK.0b013e318204c019

Liu, 2014, Low‐dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study, Exp Ther Med, 7, 604, 10.3892/etm.2013.1466

Nishida, 2018, The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J‐SSCG 2016), Acute Med Surg, 5, 3, 10.1002/ams2.322

Umemura, 2016, Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trials, J Thromb Haemost, 14, 518, 10.1111/jth.13230

Iba, 2014, Anticoagulant therapy for sepsis‐associated disseminated intravascular coagulation: the view from Japan, J Thromb Haemost, 12, 1010, 10.1111/jth.12596

Menter, 2017, Platelet "first responders" in wound response, cancer, and metastasis, Cancer Metastasis Rev, 36, 199, 10.1007/s10555-017-9682-0

Sun, 2009, Reduced thrombin generation increases host susceptibility to group A streptococcal infection, Blood, 113, 1358, 10.1182/blood-2008-07-170506

Dong, 2020, Discovering drugs to treat coronavirus disease 2019 (COVID‐19), Drug Discov Ther, 14, 58, 10.5582/ddt.2020.01012